<?xml version="1.0" encoding="UTF-8"?>
<ref id="b45-ijmm-43-01-0393" class="ref">
 <label class="label">45</label>
 <element-citation publication-type="journal" class="element-citation">
  <person-group person-group-type="author" class="person-group">
   <name class="name">
    <surname class="surname">Chiang</surname>
    <given-names class="given-names">YM</given-names>
   </name>
   <name class="name">
    <surname class="surname">Lo</surname>
    <given-names class="given-names">CP</given-names>
   </name>
   <name class="name">
    <surname class="surname">Chen</surname>
    <given-names class="given-names">YP</given-names>
   </name>
   <name class="name">
    <surname class="surname">Wang</surname>
    <given-names class="given-names">SY</given-names>
   </name>
   <name class="name">
    <surname class="surname">Yang</surname>
    <given-names class="given-names">NS</given-names>
   </name>
   <name class="name">
    <surname class="surname">Kuo</surname>
    <given-names class="given-names">YH</given-names>
   </name>
   <name class="name">
    <surname class="surname">Shyur</surname>
    <given-names class="given-names">LF</given-names>
   </name>
  </person-group>
  <article-title class="article-title">Ethyl caffeate suppresses NF-kappaB activation and its downstream inflammatory mediators, iNOS, COX-2, and PGE2 in vitro or in mouse skin</article-title>
  <source class="source">Br J Pharmacol</source>
  <volume class="volume">146</volume>
  <fpage class="fpage">352</fpage>
  <lpage class="lpage">363</lpage>
  <year class="year">2005</year>
  <pub-id pub-id-type="doi" class="pub-id">10.1038/sj.bjp.0706343</pub-id>
  <!--<pub-id pub-id-type="pmcid">1576288</pub-id>-->
  <?supplied-pmid 16041399?>
  <pub-id pub-id-type="pmid" class="pub-id">16041399</pub-id>
 </element-citation>
</ref>
